What is AMBOSS?
Headquartered in Berlin, Germany, AMBOSS has revolutionized medical knowledge acquisition and application at the point-of-care. Its comprehensive knowledge platform serves both medical students, aiding in their studies and exam preparation through an interactive library and question bank, and practicing physicians, who leverage AMBOSS for evidence-based clinical decision-making. The company's innovative approach has fundamentally altered how medical information is accessed and utilized, positioning it as a leader in digital health solutions.
How much funding has AMBOSS raised?
AMBOSS has raised a total of $298.6M across 3 funding rounds:
Series A
$5.6M
Series B
$33M
Other Financing Round
$260M
Series A (2017): $5.6M with participation from Cherry Ventures
Series B (2019): $33M led by Wellington Partners, Holtzbrinck Digital, Cherry Ventures, Partech, and Target Global
Other Financing Round (2025): $260M supported by Lightrock, M&G Investments, and Kirkbi
Key Investors in AMBOSS
Lightrock
Lightrock is a global sustainable investment platform managing over $5.5 billion, focusing on purpose-driven businesses that address significant global challenges with a commitment to impact and returns. They invest in technology-driven growth-stage companies.
M&G Investments
M&G Investments operates in the Venture Capital & Private Equity industry, headquartered in Switzerland, with a significant employee base and revenue, indicating a substantial presence in investment management.
Kirkbi
Kirkbi is a private holding and investment company that maintains majority ownership of the LEGO Group, focusing on sustainable long-term investments and managing a diverse portfolio including real estate and renewable energy.
What's next for AMBOSS?
The substantial enterprise-level funding secured by AMBOSS signals a strong commitment to its continued growth and expansion. This capital injection is expected to fuel further development of its knowledge platform, enhance its technological capabilities, and potentially broaden its market reach. The strategic nature of the recent investment suggests a focus on deepening its impact within the healthcare ecosystem and solidifying its competitive advantage through innovation and strategic partnerships.
See full AMBOSS company page
